Showing results (171-180 of 219) with videos related to
Sort By:
Pageof 22
CA: a Cancer Journal for Clinicians|February 6, 2019
Artificial intelligence in cancer imaging: Clinical challenges and applicationsWenya Linda Bi, Ahmed Hosny, Matthew B Schabath, et al.Medrxiv : the Preprint Server for Health Sciences|April 22, 2024
Pilot trial of perampanel on peritumoral hyperexcitability and clinical outcomes in newly diagnosed high-grade gliomaSteven Tobochnik, Michael S Regan, Maria K C Dorotan, et al.NPJ Genomic Medicine|July 18, 2017
Genomic landscape of high-grade meningiomasWenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, et al.Oncotarget|September 27, 2014
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomasJane B Cryan, Sam Haidar, Lori A Ramkissoon, et al.NPJ Genomic Medicine|December 22, 2017
Erratum: Genomic landscape of high-grade meningiomasWenya Linda Bi, Noah F Greenwald, Malak Abedalthagafi, et al.Journal of Neurosurgery|May 6, 2022
The New England Neurosurgical Society: growth and evolution over 70 yearsAndy Y Wang, Vaishnavi Sharma, Wenya Linda Bi, et al.Neuro-Oncology|December 8, 2021
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-makingMary Jane Lim-Fat, Gilbert C Youssef, Mehdi Touat, et al.Neuro-Oncology|December 1, 2021
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trialE Antonio Chiocca, Arnold B Gelb, Clark C Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2024
Pilot Trial of Perampanel on Peritumoral Hyperexcitability in Newly Diagnosed High-grade GliomaSteven Tobochnik, Michael S Regan, Maria K C Dorotan, et al.Frontiers in Neurology|November 16, 2020
Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain TumorsLori A Ramkissoon, Worthy Pegram, James Haberberger, et al.Pageof 22